Literature DB >> 100202

Preoperative radiotherapy in operable breast cancer: results in the Stockholm Breast Cancer Trial.

A Wallgren, O Arner, J Bergström, B Blomstedt, P O Granberg, L Karnström, L Räf, C Silfverswärd.   

Abstract

A randomized trial of preoperative radiotherapy in operable breast cancer was conducted from 1971 to 1976. The diagnosis was established by fine-needle aspiration biopsy. A dose of 4500 rad over five weeks was given to the chest wall, the breast and the lymph nodes of the axilla, the supraclavicular fossa and the internal mammary chain. Modified radical mastectomy was performed six weeks or more after completed radiotherapy. In control patients the same operation was performed without prior radiotherapy. By random allocation, one control group received no further treatment and postoperative irradiation was given to the other controls. Preoperative radiotherapy reduced the incidence of local and regional recurrence and of distant metastases, and also the mortality, as compared with the surgery only group. Postoperative radiotherapy as given in this trial gave almost equal reduction of local and regional recurrence but did not diminish the frequency of distant metastases or the mortality.

Entities:  

Mesh:

Year:  1978        PMID: 100202     DOI: 10.1002/1097-0142(197809)42:3<1120::aid-cncr2820420313>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Blood lymphocyte subpopulations in breast cancer patients following post-operative adjuvant chemotherapy or radiotherapy.

Authors:  B Petrini; J Wasserman; H Blomgren; E Baral; L E Strender; A Wallgren
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

2.  Increasing incidence and constant mortality rates of breast cancer: time trends in Stockholm County 1961-1973.

Authors:  L E Rutqvist
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer.

Authors:  H J Wanebo; P S Feldman; M C Wilhelm; J L Covell; R L Binns
Journal:  Ann Surg       Date:  1984-05       Impact factor: 12.969

4.  Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: the Southeastern Cancer Study Group experience.

Authors:  E Velez-Garcia; M Moore; C L Vogel; V Marcial; A Ketcham; A Bartolucci; C Liu; R Smalley
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

5.  Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.

Authors:  Jan Haussmann; Wilfried Budach; Carolin Nestle-Krämling; Sylvia Wollandt; Balint Tamaskovics; Stefanie Corradini; Edwin Bölke; David Krug; Tanja Fehm; Eugen Ruckhäberle; Werner Audretsch; Danny Jazmati; Christiane Matuschek
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

Review 6.  Fraction size in radiation therapy for breast conservation in early breast cancer.

Authors:  Brigid E Hickey; Melissa L James; Margot Lehman; Phil N Hider; Mark Jeffery; Daniel P Francis; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18

Review 7.  Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited.

Authors:  Christiane Matuschek; Carolin Nestle-Kraemling; Thorsten Kühn; Tanja Fehm; Edwin Bölke; Stefanie Corradini; Gerd Fastner; Kitti Maas; Clemens Seidel; Wilfried Budach
Journal:  Breast Care (Basel)       Date:  2020-04-14       Impact factor: 2.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.